Bank of Stockton’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$760K Buy
4,006
+66
+2% +$12.4K 0.21% 75
2026
Q1
$777K Sell
3,940
-592
-13% -$114K 0.24% 75
2025
Q4
$833K Buy
4,532
+2,163
+91% +$379K 0.24% 71
2025
Q3
$363K Sell
2,369
-80
-3% -$12.1K 0.1% 104
2025
Q2
$342K Sell
2,449
-56
-2% -$7.85K 0.1% 109
2025
Q1
$368K Buy
2,505
+161
+7% +$23.3K 0.12% 105
2024
Q4
$307K Buy
2,344
+273
+13% +$38.2K 0.09% 116
2024
Q3
$323K Buy
2,071
+678
+49% +$109K 0.1% 119
2024
Q2
$217K Buy
+1,393
New +$210K 0.07% 128

Other funds holding AZN

Bank of Stockton's AZN Position: Q2 2026 in Review

Bank of Stockton increased its AstraZeneca (AZN) stake by 1.7% in Q2 2026, buying an estimated $12.4K and bringing the position to 4,006 shares worth $760K. The position accounts for 0.21% of the portfolio, ranked #75.

Bank of Stockton first reported a position in AZN in Q2 2024 and has held it in 9 quarters since. The position peaked at $833K in Q4 2025. 906 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Bank of Stockton held 4,006 shares of AstraZeneca worth $760K as of Q2 2026.
  • Bank of Stockton bought 66 AstraZeneca shares in Q2 2026, an estimated $12.4K.
  • AstraZeneca made up 0.21% of Bank of Stockton's portfolio in Q2 2026, its #75 holding.
  • Bank of Stockton first reported a position in AstraZeneca in Q2 2024 and has held it in 9 quarters since.
  • Bank of Stockton's AstraZeneca position peaked at $833K in Q4 2025.
  • 906 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Bank of Stockton's 13F filing for Q2 2026, filed 29 Jul 2026.